Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among the immune-compromised patients.
This report contains market size and forecasts of Antiviral Drug Resistance in Global, including the following market information:
Global Antiviral Drug Resistance Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antiviral Drug Resistance market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunodiagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antiviral Drug Resistance include AccuBioTech Co., Ltd., ACON Laboratories, Inc., Siemens AG, BioMerieux SA, Bio-Rad Laboratories, Inc., Danaher, Abbott, BD and F. Hoffmann-La Roche Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiviral Drug Resistance companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiviral Drug Resistance Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antiviral Drug Resistance Market Segment Percentages, by Type, 2021 (%)
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Sanger Sequencing
Other Technologies
Global Antiviral Drug Resistance Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antiviral Drug Resistance Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinics
Pathology or Diagnostic Laboratories
Research Institutes
Others
Global Antiviral Drug Resistance Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antiviral Drug Resistance Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiviral Drug Resistance revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antiviral Drug Resistance revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AccuBioTech Co., Ltd.
ACON Laboratories, Inc.
Siemens AG
BioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher
Abbott
BD
F. Hoffmann-La Roche Ltd.
Trinity Biotech